WP
DICE

Woodline Partners’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Woodline Partners’s Portfolio DICE Stock Details DICE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,192,177
Closed -$34.2M – 809
2023
Q1 		$34.2M Buy
1,192,177
+197,048
+20% +$5.84M 0.46% 58
2022
Q4 		$31M Buy
995,129
+511,385
+106% +$16.7M 0.42% 55
2022
Q3 		$9.81M Sell
483,744
-153,243
-24% -$2.79M 0.14% 201
2022
Q2 		$9.89M Sell
636,987
-12,166
-2% -$209K 0.15% 178
2022
Q1 		$12.4M Buy
649,153
+399,104
+160% +$7.12M 0.2% 153
2021
Q4 		$6.33M Sell
250,049
-9
-0% -$264 0.09% 257
2021
Q3 		$8.19M Buy
+250,058
New +$8.52M 0.13% 183

Other funds holding DICE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Woodline Partners's DICE Position: Q2 2023 in Review

Woodline Partners sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q2 2023, closing a stake of 1,192,177 shares — an estimated $34.2M sold.

Woodline Partners first reported a position in DICE in Q3 2021 and held it in 7 quarters. The position peaked at $34.2M in Q1 2023. 160 funds tracked by Wall St. Rank hold DICE as of Q2 2023.

  • Woodline Partners reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Woodline Partners sold 1,192,177 DICE Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $34.2M.
  • Woodline Partners first reported a position in DICE Therapeutics, Inc. Common Stock in Q3 2021 and held it in 7 quarters.
  • Woodline Partners's DICE Therapeutics, Inc. Common Stock position peaked at $34.2M in Q1 2023.
  • 160 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q2 2023.

Based on Woodline Partners's 13F filing for Q2 2023, filed 14 Aug 2023.